Ranitidine 25 mg (as ranitidine hydrochloride 28 mg) Effervescent Oral Tablet
RxNorm 602639
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 602639 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: ranitidine 25 mg (as ranitidine hydrochloride 28 mg) Effervescent Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Ranitidine 25 mg Effervescent Oral Tablet
(Atom ID: 12349338)
FN
Full form of descriptor (FN):
Product containing precisely ranitidine (as ranitidine hydrochloride) 25 mg/1 each conventional release effervescent oral tablet (clinical drug)
(Atom ID: 11440631)
PT
Designated preferred name (PT):
Ranitidine (as ranitidine hydrochloride) 25 mg effervescent oral tablet
(Atom ID: 11441082)
SY
Synonym (SY):
Ranitidine 25 mg (as ranitidine hydrochloride 28 mg) Effervescent Oral Tablet
(Atom ID: 6337084)
Patient Education
Ranitidine
Ranitidine is used to treat ulcers; gastroesophageal reflux disease (GERD), a condition in which backward flow of acid from the stomach causes heartburn and injury of the food pipe (esophagus); and conditions where the stomach produces too much acid, such as Zollinger-Ellison syndrome. Over-the-counter ranitidine is used to prevent and treat symptoms of heartburn associated with acid indigestion and sour stomach. Ranitidine is in a class of medications called H2 blockers. It decreases the amount of acid made in the stomach.
[Learn More]
* Please review the disclaimer below.